Synthesis and mechanism of action of new purine derivatives against triple negative breast cancer
Q Zhang, G Sun, Y Huang, S Cui, T Li, L Zhao… - European Journal of …, 2023 - Elsevier
Triple negative breast cancer (TNBC) is considered to be the most difficult subtype of breast
cancer to treat because of its extremely prone to metastasis and the lack of targeted therapy …
cancer to treat because of its extremely prone to metastasis and the lack of targeted therapy …
Synthesis and mechanism of action of new purine derivatives against triple negative breast cancer.
Q Zhang, G Sun, Y Huang, S Cui, T Li… - European Journal of …, 2023 - europepmc.org
Triple negative breast cancer (TNBC) is considered to be the most difficult subtype of breast
cancer to treat because of its extremely prone to metastasis and the lack of targeted therapy …
cancer to treat because of its extremely prone to metastasis and the lack of targeted therapy …
Synthesis and mechanism of action of new purine derivatives against triple negative breast cancer
Q Zhang, G Sun, Y Huang, S Cui, T Li… - European journal of … - pubmed.ncbi.nlm.nih.gov
Triple negative breast cancer (TNBC) is considered to be the most difficult subtype of breast
cancer to treat because of its extremely prone to metastasis and the lack of targeted therapy …
cancer to treat because of its extremely prone to metastasis and the lack of targeted therapy …